Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Garrison

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
The Journal of Trauma and Acute Care Surgery|March 24, 2012
Impact of isolated acetabular and lower extremity fractures on long-term outcomeRoman Pfeifer, Boris A Zelle, Philipp Kobbe, et al.
Journal of Clinical and Translational Science|December 15, 2025
From basic science to prevention - the imperative for a convergence science approach for cardio- and cerebrovascular risk reduction in females with diabetesAmparo C Villablanca, Bridgette P Smith, Brooke E Wickman, et al.
Acta Physiologica Hungarica|January 1, 1993
The comparative antiarrhythmic and proarrhythmic activity of a 3,7-diheterobicyclo[3.3.1]nonane, BRB-I-28, and lidocaine in the 1-4-day-old infarcted dog heartT Fazekas, B J Scherlag, P Mabo, et al.
Journal of the Neurological Sciences|January 7, 1998
A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile. The Syntex-Synergen ALS/CNTF Study GroupD McGuire, L Garrison, C Armon, et al.
Molecular Biology of the Cell|June 15, 2007
The role of p58IPK in protecting the stressed endoplasmic reticulumD Thomas Rutkowski, Sang-Wook Kang, Alan G Goodman, et al.
Nature Neuroscience|June 24, 2008
Pungent agents from Szechuan peppers excite sensory neurons by inhibiting two-pore potassium channelsDiana M Bautista, Yaron M Sigal, Aaron D Milstein, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 28, 1998
Biologic activity of interleukin 1 (IL-1) alpha in patients with refractory malignanciesM A Rosenthal, D Dennis, L Liebes, et al.
Journal of Cardiovascular Pharmacology|August 1, 1996
Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heartT Fazekas, L Carlsson, B J Scherlag, et al.
Cell|November 27, 2012
Molecular profiling of activated neurons by phosphorylated ribosome captureZachary A Knight, Keith Tan, Kivanc Birsoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancyJ M Vose, J E Anderson, P J Bierman, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
The Journal of Trauma and Acute Care Surgery|March 24, 2012
Impact of isolated acetabular and lower extremity fractures on long-term outcomeRoman Pfeifer, Boris A Zelle, Philipp Kobbe, et al.
Journal of Clinical and Translational Science|December 15, 2025
From basic science to prevention - the imperative for a convergence science approach for cardio- and cerebrovascular risk reduction in females with diabetesAmparo C Villablanca, Bridgette P Smith, Brooke E Wickman, et al.
Acta Physiologica Hungarica|January 1, 1993
The comparative antiarrhythmic and proarrhythmic activity of a 3,7-diheterobicyclo[3.3.1]nonane, BRB-I-28, and lidocaine in the 1-4-day-old infarcted dog heartT Fazekas, B J Scherlag, P Mabo, et al.
Journal of the Neurological Sciences|January 7, 1998
A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile. The Syntex-Synergen ALS/CNTF Study GroupD McGuire, L Garrison, C Armon, et al.
Molecular Biology of the Cell|June 15, 2007
The role of p58IPK in protecting the stressed endoplasmic reticulumD Thomas Rutkowski, Sang-Wook Kang, Alan G Goodman, et al.
Nature Neuroscience|June 24, 2008
Pungent agents from Szechuan peppers excite sensory neurons by inhibiting two-pore potassium channelsDiana M Bautista, Yaron M Sigal, Aaron D Milstein, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 28, 1998
Biologic activity of interleukin 1 (IL-1) alpha in patients with refractory malignanciesM A Rosenthal, D Dennis, L Liebes, et al.
Journal of Cardiovascular Pharmacology|August 1, 1996
Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heartT Fazekas, L Carlsson, B J Scherlag, et al.
Cell|November 27, 2012
Molecular profiling of activated neurons by phosphorylated ribosome captureZachary A Knight, Keith Tan, Kivanc Birsoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancyJ M Vose, J E Anderson, P J Bierman, et al.
Pageof 17